BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26621941)

  • 1. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome?
    Watson L; Lalji A; Bodla S; Muls A; Andreyev HJ; Shaw C
    Clin Med (Lond); 2015 Dec; 15(6):536-40. PubMed ID: 26621941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption - outcomes in patients previously treated for cancer.
    Jackson A; Lalji A; Kabir M; Muls A; Gee C; Vyoral S; Shaw C; Andreyev HJN
    Clin Med (Lond); 2017 Oct; 17(5):412-418. PubMed ID: 28974589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
    Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
    Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.
    Kurien M; Evans KE; Leeds JS; Hopper AD; Harris A; Sanders DS
    Scand J Gastroenterol; 2011 Jul; 46(7-8):818-22. PubMed ID: 21492055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea.
    Borghede MK; Schlütter JM; Agnholt JS; Christensen LA; Gormsen LC; Dahlerup JF
    Eur J Intern Med; 2011 Dec; 22(6):e137-40. PubMed ID: 22075299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes from treating bile acid malabsorption using a multidisciplinary approach.
    Gupta A; Muls AC; Lalji A; Thomas K; Watson L; Shaw C; Andreyev HJ
    Support Care Cancer; 2015 Oct; 23(10):2881-90. PubMed ID: 25693765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
    Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy.
    Orekoya O; McLaughlin J; Leitao E; Johns W; Lal S; Paine P
    Clin Med (Lond); 2015 Jun; 15(3):252-7. PubMed ID: 26031975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea.
    Gracie DJ; Kane JS; Mumtaz S; Scarsbrook AF; Chowdhury FU; Ford AC
    Neurogastroenterol Motil; 2012 Nov; 24(11):983-e538. PubMed ID: 22765392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.
    Wedlake L; A'Hern R; Russell D; Thomas K; Walters JR; Andreyev HJ
    Aliment Pharmacol Ther; 2009 Oct; 30(7):707-17. PubMed ID: 19570102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study.
    Flores V; Martínez-Lozano H; Bighelli F; Orcajo J; García-Lledó J; Alonso-Farto JC; Menchén L
    BMC Gastroenterol; 2021 Feb; 21(1):56. PubMed ID: 33563227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are bile acid malabsorption and bile acid diarrhoea important causes of loose stool complicating cancer therapy?
    Phillips F; Muls AC; Lalji A; Andreyev HJ
    Colorectal Dis; 2015 Aug; 17(8):730-4. PubMed ID: 25728737
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Baena García A; Partida Palma F; García Martínez S; de Bonilla Candau M; Pajares Vinardell M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(5):305-311. PubMed ID: 30745130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the 75selenium homotaurocholic acid retention test (SeHCAT test) in diagnosis of diarrhea].
    Balzer K; Schmitt G; Reiners C; Goebell H
    Med Klin (Munich); 1995 Jan; 90(1):27-32. PubMed ID: 7885300
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mena Bares LM; Carmona Asenjo E; García Sánchez MV; Moreno Ortega E; Maza Muret FR; Guiote Moreno MV; Santos Bueno AM; Iglesias Flores E; Benítez Cantero JM; Vallejo Casas JA
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):37-47. PubMed ID: 27765536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention.
    Merrick MV; Eastwood MA; Ford MJ
    Br Med J (Clin Res Ed); 1985 Mar; 290(6469):665-8. PubMed ID: 3918708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine.
    Sinha L; Liston R; Testa HJ; Moriarty KJ
    Aliment Pharmacol Ther; 1998 Sep; 12(9):839-44. PubMed ID: 9768525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea.
    Brydon WG; Nyhlin H; Eastwood MA; Merrick MV
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):117-23. PubMed ID: 8723414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
    Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
    Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.